Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. EXEL

Market Cap: $14.11B

EI

Exelixis, Inc.

EXEL
NASDAQ (NASDAQ Global Select)USD
Purchase EXEL
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin96.48%
EBITDA Margin42.69%
EBIT Margin41.82%
Pre-tax Margin42.51%
Net Profit Margin35.33%
Earnings Yield6.11%
Valuation Multiples
Price / Book7.63
Price / Sales5.79
Price / Earnings17.06
PEG0.32
Forward PEG0.95
EV / Sales5.74
EV / EBITDA13.45
EV / Operating Cash Flow11.82
EV / Free Cash Flow11.85
Price / Free Cash Flow11.95
Price / Operating Cash Flow11.89
Cash Flow & Capital
Free Cash Flow / Share$4.71
Operating Cash Flow / Share$4.72
Free Cash Flow Yield8.37%
Capex / Revenue0.11%
Capex / Operating Cash Flow0.22%
Capex / Depreciation0.09
Stock Compensation / Revenue4.62%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio3.46
Quick Ratio3.38
Cash Ratio0.78
Debt / Assets0.07
Debt / Capital0.08
Debt / Equity0.09
Long-Term Debt / Capital0.00
Debt / Market Cap0.00%
Net Debt / EBITDA-0.11
Solvency Ratio1.36
Financial Leverage1.35
Efficiency & Working Capital
Asset Turnover0.98
Fixed Asset Turnover7.15
Inventory Turnover2.98
Receivables Turnover7.28
Payables Turnover2.19
Days Sales Outstanding50.14
Days Inventory Outstanding122.41
Days Payables Outstanding166.43
Operating Cycle172.55
Cash Conversion Cycle6.11
Working Capital Turnover2.82
Returns & Quality
Return on Equity42.49%
Return on Assets34.50%
Return on Invested Capital37.87%
ROCE45.56%
Return on Tangible Assets35.41%
Operating Return on Assets38.19%
Income Quality1.38
Tax Burden0.83
Interest Burden1.02
Balance Sheet & Intrinsic Metrics
Enterprise Value$13.99B
Invested Capital$1.29B
Working Capital$888.9M
Tangible Asset Value$1.78B
Net Current Asset Value$600.35M
Graham Number$23.82
Graham Net-Net$1.81
Book Value / Share$7.35
Tangible Book Value / Share$7.1
Cash / Share$3.35
Financial Health Scores
Piotroski Score7
Altman Z-Score15.92
Revenue$2.44B
EBIT$1.02B
Market Cap$14.44B
Working Capital$888.9M
Retained Earnings$-262.53M
Total Assets$2.49B
Total Liabilities$650.47M